CAS NO: | 167354-41-8 |
生物活性 | Zosuquidar (LY335979) is aP-glycoprotein(P-gp) inhibitor (Ki=59 nM). Zosuquidar shows anti-tumor activities, and can be used in acute myelogenous leukemia (AML) research[1][2][3]. | ||||||||||||||||
体外研究 (In Vitro) | Zosuquidar (0.3 μM; 48 h) treatment enhances the cytotoxicity of DNR (substrates for P-glycoproteins) in P-glycoproteins active cell lines[2]. Cell Cytotoxicity Assay[2]
Cell Cytotoxicity Assay[1]
| ||||||||||||||||
体内研究 (In Vivo) | Zosuquidar (intraperitoneal injection; 30, 10, 3, or 1 mg/kg; once daily; 5 d) treatment shows a significant increase in life span[1].
| ||||||||||||||||
Clinical Trial | |||||||||||||||||
分子量 | 527.60 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C32H31F2N3O2 | ||||||||||||||||
CAS 号 | 167354-41-8 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 8.33 mg/mL(15.79 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024 |